Skip to search.
 FTSE 100 Up 0.63%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
4.08 Up 0.09(2.26%) 28 Jul 21:00
Add to Portfolio
Prev Close:3.99
Open:4.04
Bid:4.00 x 200
Ask:4.26 x 1100
1y Target Est:7.70
Beta:-0.62
Earnings Date:30 Jul - 3 Aug (Est.)
Day's Range:3.94 - 4.11
52wk Range:3.26 - 6.28
Volume:1,738,008
Avg Vol (3m):2,719,790
Market Cap:987.52m
P/E (ttm):N/A
EPS (ttm):-0.27
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARNAUp 2.26%987.52m
GSKUp 0.26%100.73b
OREXUp 4.28%549.72m
RHHBYUp 1.33%245.66b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):22.77
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.51
Quarterly EPS Est (Jun-15) :-0.14
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):0.39

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback